Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN)
CUSIP: 23954D109
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 103,269,345
- Total 13F shares
- 41,477,196
- Share change
- +4,524,714
- Total reported value
- $698,277,000
- Price per share
- $16.85
- Number of holders
- 57
- Value change
- +$74,959,681
- Number of buys
- 38
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 23954D109?
CUSIP 23954D109 identifies DAWN - Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 23954D109:
Top shareholders of DAWN - Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
4.8%
|
4,965,588
|
$117,833,000 | — | 30 Sep 2021 | |
| TAKEDA PHARMACEUTICAL CO LTD |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
6,120,124
|
$71,544,250 | — | 07 Dec 2021 | |
| FMR LLC |
13F
|
Company |
2.1%
|
2,161,909
|
$51,303,000 | — | 30 Sep 2021 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.7%
|
1,710,730
|
$40,596,000 | — | 30 Sep 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.5%
|
1,506,326
|
$34,865,000 | — | 30 Sep 2021 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
1.2%
|
1,211,396
|
$28,746,000 | — | 30 Sep 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
1.2%
|
1,189,943
|
$28,237,000 | — | 30 Sep 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.99%
|
1,022,483
|
$23,384,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.79%
|
820,073
|
$19,461,000 | — | 30 Sep 2021 | |
| BVF INC/IL |
13F
|
Company |
0.78%
|
810,284
|
$19,228,000 | — | 30 Sep 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.57%
|
590,527
|
$14,013,000 | — | 30 Sep 2021 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.54%
|
556,047
|
$13,195,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.5%
|
521,273
|
$12,370,000 | — | 30 Sep 2021 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.42%
|
431,446
|
$10,238,000 | — | 30 Sep 2021 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.36%
|
376,439
|
$8,933,000 | — | 30 Sep 2021 | |
| Samsara BioCapital, LLC |
13F
|
Company |
0.2%
|
202,500
|
$4,805,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.18%
|
186,627
|
$4,428,000 | — | 30 Sep 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.17%
|
177,945
|
$4,223,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.12%
|
124,032
|
$2,943,000 | — | 30 Sep 2021 | |
| Logos Global Management LP |
13F
|
Company |
0.05%
|
52,069
|
$2,798,000 | — | 30 Sep 2021 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.1%
|
103,200
|
$2,449,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.09%
|
98,099
|
$2,328,000 | — | 30 Sep 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.09%
|
90,000
|
$2,136,000 | — | 30 Sep 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.07%
|
75,226
|
$1,786,000 | — | 30 Sep 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.03%
|
26,795
|
$635,000 | — | 30 Sep 2021 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.02%
|
16,856
|
$400,000 | — | 30 Sep 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.01%
|
14,961
|
$355,000 | — | 30 Sep 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
10,053
|
$238,000 | — | 30 Sep 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
6,339
|
$150,000 | — | 30 Sep 2021 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
6,035
|
$143,000 | — | 30 Sep 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
5,957
|
$141,000 | — | 30 Sep 2021 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0%
|
4,806
|
$114,046 | — | 30 Sep 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
4,223
|
$100,000 | — | 30 Sep 2021 | |
| METROPOLITAN LIFE INSURANCE CO/NY |
13F
|
Company |
0%
|
3,636
|
$86,282 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
2,961
|
$70,000 | — | 30 Sep 2021 | |
| STRS OHIO |
13F
|
Company |
0%
|
2,500
|
$59,000 | — | 30 Sep 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
1,376
|
$33,000 | — | 30 Sep 2021 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
1,279
|
$30,000 | — | 30 Sep 2021 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,027
|
$24,000 | — | 30 Sep 2021 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
845
|
$20,000 | — | 30 Sep 2021 | |
| Capital Analysts, LLC |
13F
|
Company |
0%
|
750
|
$18,000 | — | 30 Sep 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
514
|
$12,000 | — | 30 Sep 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
478
|
$11,000 | — | 30 Sep 2021 | |
| Jacobi Capital Management LLC |
13F
|
Company |
0%
|
200
|
$5,000 | — | 30 Sep 2021 | |
| Red Tortoise LLC |
13F
|
Company |
0%
|
196
|
$4,000 | — | 30 Sep 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
59
|
$1,000 | — | 30 Sep 2021 |
Institutional Holders of Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN) as of Q4 2021
As of 31 Dec 2021,
Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,477,196 shares.
The largest 10 holders included
Canaan Partners XI LLC, Atlas Venture Life Science Advisors, LLC, RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, FMR LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), PRICE T ROWE ASSOCIATES INC /MD/, BOXER CAPITAL, LLC, VIKING GLOBAL INVESTORS LP, and JANUS HENDERSON GROUP PLC.
This page lists
57
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
43
Q4 2021 holders
57
Holder diff
14
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.